Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Pritchard

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
American Journal of Epidemiology|May 29, 2024
Detecting changes in population trends in infection surveillance using community SARS-CoV-2 prevalence as an exemplarEmma Pritchard, Karina-Doris Vihta, David W Eyre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 8, 2021
Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United KingdomKarina Doris Vihta, Koen B Pouwels, Tim E A Peto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 2, 2022
Omicron-associated changes in SARS-CoV-2 symptoms in the United KingdomKarina Doris Vihta, Koen B Pouwels, Tim Ea Peto, et al.
The Lancet. Public Health|December 14, 2020
Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection SurveyKoen B Pouwels, Thomas House, Emma Pritchard, et al.
Nature Medicine|October 15, 2021
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UKKoen B Pouwels, Emma Pritchard, Philippa C Matthews, et al.
Elife|July 12, 2021
Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over timeA Sarah Walker, Emma Pritchard, Thomas House, et al.
Nature Medicine|June 10, 2021
Impact of vaccination on new SARS-CoV-2 infections in the United KingdomEmma Pritchard, Philippa C Matthews, Nicole Stoesser, et al.
The New England Journal of Medicine|December 8, 2021
Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United KingdomA Sarah Walker, Karina-Doris Vihta, Owen Gethings, et al.
BMC Medicine|March 27, 2024
SARS-CoV-2, influenza A/B and respiratory syncytial virus positivity and association with influenza-like illness and self-reported symptoms, over the 2022/23 winter season in the UK: a longitudinal surveillance cohortElisabeth Dietz, Emma Pritchard, Koen Pouwels, et al.
The Lancet Regional Health. Europe|December 20, 2021
Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillanceEmma Pritchard, Joel Jones, Karina-Doris Vihta, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
American Journal of Epidemiology|May 29, 2024
Detecting changes in population trends in infection surveillance using community SARS-CoV-2 prevalence as an exemplarEmma Pritchard, Karina-Doris Vihta, David W Eyre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 8, 2021
Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United KingdomKarina Doris Vihta, Koen B Pouwels, Tim E A Peto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 2, 2022
Omicron-associated changes in SARS-CoV-2 symptoms in the United KingdomKarina Doris Vihta, Koen B Pouwels, Tim Ea Peto, et al.
The Lancet. Public Health|December 14, 2020
Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection SurveyKoen B Pouwels, Thomas House, Emma Pritchard, et al.
Nature Medicine|October 15, 2021
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UKKoen B Pouwels, Emma Pritchard, Philippa C Matthews, et al.
Elife|July 12, 2021
Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over timeA Sarah Walker, Emma Pritchard, Thomas House, et al.
Nature Medicine|June 10, 2021
Impact of vaccination on new SARS-CoV-2 infections in the United KingdomEmma Pritchard, Philippa C Matthews, Nicole Stoesser, et al.
The New England Journal of Medicine|December 8, 2021
Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United KingdomA Sarah Walker, Karina-Doris Vihta, Owen Gethings, et al.
BMC Medicine|March 27, 2024
SARS-CoV-2, influenza A/B and respiratory syncytial virus positivity and association with influenza-like illness and self-reported symptoms, over the 2022/23 winter season in the UK: a longitudinal surveillance cohortElisabeth Dietz, Emma Pritchard, Koen Pouwels, et al.
The Lancet Regional Health. Europe|December 20, 2021
Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillanceEmma Pritchard, Joel Jones, Karina-Doris Vihta, et al.
Pageof 3